New mutation of the TP53 gene associated with the hereditary breast cancer in a young Tuvinian woman

Background. The identification of the ethnospecific mutations associated with hereditary breast cancer remains challenging. Next generation sequencing (Ngs) technology fully enables the compilation of germline variants associated with the risk for inherited diseases. Despite the success of the Ngs,...

Full description

Bibliographic Details
Main Authors: P. A. Gervas, A. Yu. Molokov, A. A. Zarubin, A. A. Ponomareva, N. N. Babyshkina, V. A. Belyavskaya, L. F. Pisareva, E. L. Choynzonov, N. V. Cherdyntseva
Format: Article
Language:Russian
Published: Russian Academy of Sciences, Tomsk National Research Medical Center 2022-01-01
Series:Сибирский онкологический журнал
Subjects:
Online Access:https://www.siboncoj.ru/jour/article/view/2000
_version_ 1797875703551623168
author P. A. Gervas
A. Yu. Molokov
A. A. Zarubin
A. A. Ponomareva
N. N. Babyshkina
V. A. Belyavskaya
L. F. Pisareva
E. L. Choynzonov
N. V. Cherdyntseva
author_facet P. A. Gervas
A. Yu. Molokov
A. A. Zarubin
A. A. Ponomareva
N. N. Babyshkina
V. A. Belyavskaya
L. F. Pisareva
E. L. Choynzonov
N. V. Cherdyntseva
author_sort P. A. Gervas
collection DOAJ
description Background. The identification of the ethnospecific mutations associated with hereditary breast cancer remains challenging. Next generation sequencing (Ngs) technology fully enables the compilation of germline variants associated with the risk for inherited diseases. Despite the success of the Ngs, up to 20 % of molecular tests report genetic variant of unknown significance (Vus) or novel variants that have never been previously described and their clinical significances are unknown. To obtain extended information about the variants of the unknown significance, it is necessary to use an alternative approach for the analysis of the Ngs data. To obtain extended characteristic about the unknown significance variants, it is necessary to search for additional tools for the analysis of the Ngs data. Material and methods. We reclassified the mutation of the unknown significance using the activedrivedb database that assessed the effect of mutations on sites of post-translational modifications, and the proteinpaint tool that complemented the existing cancer genome portals and provided a comprehensive and intuitive view of cancer genomic data. Results. In this study, we report a 44-year-old tuvinian woman with a family history of breast cancer. Based on the Ngs data, mutational analysis revealed the presence of the lrg_321t1: c.80c>t heterozygous variant in exon 2, which led to the proline to leucine change at codon 27 of the protein. In the dbpubmed database, this mutation was determined as unknown significance due to data limitation. According to the data of the activedriverdb tool, this mutation is located distally at the site of post-translational protein modification, which is responsible for binding to kinases that regulate genes of the cell cycle, etc. (atm, chek2, cdk, mapk). In accordance with proteinpaint tool, the lrg_321t1: c.80c>t mutation is located in functionally specialized transactivation domains and codon of the tp53 gene, where the pathogenic mutation associated with li-Fraumeni syndrome has been earlier described. Conclusion. This report is the first to describe a new variant in the tp53 gene (rs1555526933), which is likely to be associated with hereditary cancer-predisposing syndrome, including li-Fraumeni syndrome, in a tuvinian Bc patient with young-onset and familial Bc.
first_indexed 2024-04-10T01:51:49Z
format Article
id doaj.art-1c1195da8e504c0c90378ec055b8c48f
institution Directory Open Access Journal
issn 1814-4861
2312-3168
language Russian
last_indexed 2024-04-10T01:51:49Z
publishDate 2022-01-01
publisher Russian Academy of Sciences, Tomsk National Research Medical Center
record_format Article
series Сибирский онкологический журнал
spelling doaj.art-1c1195da8e504c0c90378ec055b8c48f2023-03-13T09:05:55ZrusRussian Academy of Sciences, Tomsk National Research Medical CenterСибирский онкологический журнал1814-48612312-31682022-01-0120616417010.21294/1814-4861-2021-20-6-164-170936New mutation of the TP53 gene associated with the hereditary breast cancer in a young Tuvinian womanP. A. Gervas0A. Yu. Molokov1A. A. Zarubin2A. A. Ponomareva3N. N. Babyshkina4V. A. Belyavskaya5L. F. Pisareva6E. L. Choynzonov7N. V. Cherdyntseva8Научно-исследовательский институт онкологии, Томский национальный исследовательский медицинский центр Российской академии наукНаучно-исследовательский институт онкологии, Томский национальный исследовательский медицинский центр Российской академии наукНаучно-исследовательский институт медицинской генетики, Томский национальный исследовательский медицинский центр, Российская академия наукНаучно-исследовательский институт онкологии, Томский национальный исследовательский медицинский центр Российской академии наукНаучно-исследовательский институт онкологии, Томский национальный исследовательский медицинский центр Российской академии наукФБУН «Государственный научный центр вирусологии и биотехнологии «Вектор»Научно-исследовательский институт онкологии, Томский национальный исследовательский медицинский центр Российской академии наукНаучно-исследовательский институт онкологии, Томский национальный исследовательский медицинский центр Российской академии наукНаучно-исследовательский институт онкологии, Томский национальный исследовательский медицинский центр Российской академии наукBackground. The identification of the ethnospecific mutations associated with hereditary breast cancer remains challenging. Next generation sequencing (Ngs) technology fully enables the compilation of germline variants associated with the risk for inherited diseases. Despite the success of the Ngs, up to 20 % of molecular tests report genetic variant of unknown significance (Vus) or novel variants that have never been previously described and their clinical significances are unknown. To obtain extended information about the variants of the unknown significance, it is necessary to use an alternative approach for the analysis of the Ngs data. To obtain extended characteristic about the unknown significance variants, it is necessary to search for additional tools for the analysis of the Ngs data. Material and methods. We reclassified the mutation of the unknown significance using the activedrivedb database that assessed the effect of mutations on sites of post-translational modifications, and the proteinpaint tool that complemented the existing cancer genome portals and provided a comprehensive and intuitive view of cancer genomic data. Results. In this study, we report a 44-year-old tuvinian woman with a family history of breast cancer. Based on the Ngs data, mutational analysis revealed the presence of the lrg_321t1: c.80c>t heterozygous variant in exon 2, which led to the proline to leucine change at codon 27 of the protein. In the dbpubmed database, this mutation was determined as unknown significance due to data limitation. According to the data of the activedriverdb tool, this mutation is located distally at the site of post-translational protein modification, which is responsible for binding to kinases that regulate genes of the cell cycle, etc. (atm, chek2, cdk, mapk). In accordance with proteinpaint tool, the lrg_321t1: c.80c>t mutation is located in functionally specialized transactivation domains and codon of the tp53 gene, where the pathogenic mutation associated with li-Fraumeni syndrome has been earlier described. Conclusion. This report is the first to describe a new variant in the tp53 gene (rs1555526933), which is likely to be associated with hereditary cancer-predisposing syndrome, including li-Fraumeni syndrome, in a tuvinian Bc patient with young-onset and familial Bc.https://www.siboncoj.ru/jour/article/view/2000наследственные мутации, рак молочной железы, малые народы россии, этносы, тувинцы
spellingShingle P. A. Gervas
A. Yu. Molokov
A. A. Zarubin
A. A. Ponomareva
N. N. Babyshkina
V. A. Belyavskaya
L. F. Pisareva
E. L. Choynzonov
N. V. Cherdyntseva
New mutation of the TP53 gene associated with the hereditary breast cancer in a young Tuvinian woman
Сибирский онкологический журнал
наследственные мутации, рак молочной железы, малые народы россии, этносы, тувинцы
title New mutation of the TP53 gene associated with the hereditary breast cancer in a young Tuvinian woman
title_full New mutation of the TP53 gene associated with the hereditary breast cancer in a young Tuvinian woman
title_fullStr New mutation of the TP53 gene associated with the hereditary breast cancer in a young Tuvinian woman
title_full_unstemmed New mutation of the TP53 gene associated with the hereditary breast cancer in a young Tuvinian woman
title_short New mutation of the TP53 gene associated with the hereditary breast cancer in a young Tuvinian woman
title_sort new mutation of the tp53 gene associated with the hereditary breast cancer in a young tuvinian woman
topic наследственные мутации, рак молочной железы, малые народы россии, этносы, тувинцы
url https://www.siboncoj.ru/jour/article/view/2000
work_keys_str_mv AT pagervas newmutationofthetp53geneassociatedwiththehereditarybreastcancerinayoungtuvinianwoman
AT ayumolokov newmutationofthetp53geneassociatedwiththehereditarybreastcancerinayoungtuvinianwoman
AT aazarubin newmutationofthetp53geneassociatedwiththehereditarybreastcancerinayoungtuvinianwoman
AT aaponomareva newmutationofthetp53geneassociatedwiththehereditarybreastcancerinayoungtuvinianwoman
AT nnbabyshkina newmutationofthetp53geneassociatedwiththehereditarybreastcancerinayoungtuvinianwoman
AT vabelyavskaya newmutationofthetp53geneassociatedwiththehereditarybreastcancerinayoungtuvinianwoman
AT lfpisareva newmutationofthetp53geneassociatedwiththehereditarybreastcancerinayoungtuvinianwoman
AT elchoynzonov newmutationofthetp53geneassociatedwiththehereditarybreastcancerinayoungtuvinianwoman
AT nvcherdyntseva newmutationofthetp53geneassociatedwiththehereditarybreastcancerinayoungtuvinianwoman